Finally, there is an urgent need for clinical trials to confirm the role of CPAP therapy in patients with lung cancer with coexisting OSA, as well as to validate the efficacy and safety of immune checkpoint inhibitors and anti-VEGF monoclonal antibodies in this particular group. This evidence concerns the gene VEGFA and lung carcinoma.